Pharma Company Of The Year


This award recognises a European Pharma or large-cap Biotech company that has demonstrated superior excellence in strategy, process, focus and execution and contributed to the broader life science industry. 
Qualifying criteria

  • Open to all pharma companies and large cap large cap biotech companies with a market capitalisation that is €10bn or above.
  • Open to all pharma / large cap companies with European Headquarters
  • Criteria relates to the period between 1 October 2020 and 1 October 2021

Judges will be paying particular attention to:

  • Targeting of unmet medical need / use of innovative approaches to product development
  • Pipeline progress through in-development / clinical stages / market approval
  • Closure of fundraises and strategic financing rounds
  • Key stages of strategic development / partnerships
  • Implementation of new technologies, processes for strategic advantage
  • Wider industry contribution and advocacy
Before entering the nomination site please ensure you have:

1. Selected the most appropriate category(s) you'll be entering and check for validity of entry
2. Identified your lead applicant / internal champion who will respond to any correspondence from the ELA team
3. Pre-prepared your submission in accordance with the category criteria, spending time crafting your detailed submission.
4. A company logo and your website URL that you can upload alongside your submission